0001179110-13-008498.txt : 20130515
0001179110-13-008498.hdr.sgml : 20130515
20130515190746
ACCESSION NUMBER: 0001179110-13-008498
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130513
FILED AS OF DATE: 20130515
DATE AS OF CHANGE: 20130515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brinkley David L
CENTRAL INDEX KEY: 0001302445
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 13849137
MAIL ADDRESS:
STREET 1: 901 GATEWAY BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THERAVANCE INC
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508086000
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: S. SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
4
1
edgar.xml
FORM 4 -
X0306
4
2013-05-13
0
0001080014
THERAVANCE INC
THRX
0001302445
Brinkley David L
THERAVANCE, INC.
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Head of Business Dev.
Common Stock
2013-05-13
4
M
0
16129
34.00
A
71129
D
Common Stock
2013-05-13
4
S
0
16129
40.33
D
55000
D
Stock Option (Right to Buy)
34.00
2013-05-13
4
M
0
16129
0
D
2017-02-13
Common Stock
16129
0
D
DISPOSITIONS MADE PURSUANT TO A PLAN INTENDED TO COMPLY WITH RULE 10b5-1(c).
This transaction was executed in multiple trades at prices ranging from $40.06 to $40.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Immediately exercisable.
David L. Brinkley
2013-05-15